Contact Us
Drug Search Results
More Filters [+]

Ganciclovir

Alternative Names: ganciclovir, gancyclovir, cytovene, zirgan, gv-550, gv 550, gv550, ganzyk-rtu, vitrasert
Latest Update: 2024-12-18
Latest Update Note: Clinical Trial Update

Product Description

Ganciclovir capsules are used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people whose immune system is not working normally. Ganciclovir capsules are used to treat CMV retinitis after the condition has been controlled by intravenous (injected into a vein) ganciclovir. Ganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have acquired immunodeficiency syndrome (AIDS) or who have received an organ transplant and are at risk of CMV disease. Ganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV. (Sourced from: https://medlineplus.gov/druginfo/meds/a605011.html)

Mechanisms of Action: DNA Polymerase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Czech | Denmark | Dominican Republic | Ecuador | Egypt | European Medicines Agency | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Retinitis | Acquired Immunodeficiency Syndrome | Keratitis | Keratitis, Dendritic | Keratitis, Herpetic | Retinitis | Cytomegalovirus Retinitis | Acquired Immunodeficiency Syndrome

Known Adverse Events: Anemia | Leukopenia | Sepsis | Diarrhea | Hyperemia | Keratitis | Pregnancy Outcomes | Keratitis, Herpetic | Abdominal Pain | Headache | Labor Pain | Pain Unspecified | Hyperhidrosis | Dyspnea | Asthenia

Company: Hoffmann-La Roche
Company Location: BASEL SWITZERLAND V8
Company CEO: Severin Schwan
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ganciclovir

Countries in Clinic: Japan

Active Clinical Trial Count: 1

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
jRCT2051210064

P3

Active, not recruiting

Unknown

2022-12-31

Recent News Events

Date

Type

Title

06/24/2024

News Article

 Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

12/21/2023

News Article

 Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies

11/01/2023

News Article

 Cytomegalovirus Retinitis Market to Notice Prominent Growth of 269.41 Million By 2030, Size, Share, Trends, Demand And Industry Growth

09/08/2023

News Article

 Ganciclovir Sodium Market Research Report 2023 by Product Type, Application, Region And Forecast to 2031

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions